• / Free eNewsletters & Magazine
  • / My Account
Home>Funds>iShares Nasdaq Biotechnology

iShares Nasdaq Biotechnology

  1. All
  2. Morningstar Articles
  3. 3rd Party
  4. Investing
  1. Where Are the Opportunities in U.S. Health Care?

    As the sector has continued to best the broader market, a look both at the dynamics that would drive further outperformance by the sector and at funds that investors can use to tap those themes.

  2. UPDATE: S&P clears the 2,000 mark, reaches -2-

    UPDATE: S&P clears the 2,000 mark, reaches -2-

  3. UPDATE: S&P clears the 2,000 mark, reaches -4-

    UPDATE: S&P clears the 2,000 mark, reaches -4-

  4. UPDATE: S&P clears the 2,000 mark, reaches -7-

    UPDATE: S&P clears the 2,000 mark, reaches -7-

  5. UPDATE: S&P clears the 2,000 mark, reaches -3-

    UPDATE: S&P clears the 2,000 mark, reaches -3-

  6. UPDATE: S&P clears the 2,000 mark, reaches -5-

    UPDATE: S&P clears the 2,000 mark, reaches -5-

  7. UPDATE: S&P clears the 2,000 mark, reaches -6-

    UPDATE: S&P clears the 2,000 mark, reaches -6-

  8. UPDATE: S&P clears the 2,000 mark, reaches uncharted territory

    UPDATE: S&P clears the 2,000 mark, reaches uncharted territory

  9. UPDATE: Nasdaq breaks out, reaches -3-

    UPDATE: Nasdaq breaks out, reaches -3-

  10. UPDATE: Nasdaq breaks out, reaches -4-

    UPDATE: Nasdaq breaks out, reaches -4-

12345
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.